|
CA1320906C
(en)
|
1986-06-04 |
1993-08-03 |
Daniel R. Twardzik |
Interleukin-2 induced antineoplastic peptide
|
|
WO1990009798A1
(en)
|
1989-02-24 |
1990-09-07 |
Immunotherapeutics, Inc. |
Immobilized cytokines
|
|
GR1001034B
(el)
|
1989-07-21 |
1993-03-31 |
Ortho Pharma Corp |
Μεθοδος διεγερσης του πολλαπλασιασμου λεμφοκυτταρων περιφερειακου αιματος.
|
|
US5415874A
(en)
|
1989-10-31 |
1995-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Natural killer cell lines and clones with antigen specificity
|
|
US6194204B1
(en)
|
1996-08-02 |
2001-02-27 |
Center For Blood Research, Inc. |
Enrichment of dendritic cells from blood
|
|
DE19813759C1
(de)
|
1998-03-27 |
1999-07-15 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Induktion einer durch NK-Zellen vermittelten Immunantwort
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
EP1409650B1
(en)
|
2001-05-30 |
2006-04-12 |
Fondazione Telethon |
Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof
|
|
US20030068306A1
(en)
|
2001-09-14 |
2003-04-10 |
Dilber Mehmet Sirac |
Medium
|
|
US7544355B2
(en)
|
2002-03-13 |
2009-06-09 |
Universita Degli Studi Di Perugia |
Methods and compositions for allogeneic transplantation
|
|
MXPA04012116A
(es)
|
2002-06-07 |
2005-04-19 |
Zymogenetics Inc |
Uso del il-21 en cancer y otras aplicaciones terapeuticas.
|
|
DK1523582T3
(da)
|
2002-07-18 |
2009-03-02 |
Univ Washington |
Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
|
|
WO2004031361A2
(en)
|
2002-10-03 |
2004-04-15 |
University Of Rochester |
Three-dimensional peripheral lymphoid organ cell cultures
|
|
JP4033390B2
(ja)
|
2002-10-30 |
2008-01-16 |
独立行政法人科学技術振興機構 |
不死化ナチュラルキラー細胞株
|
|
EP1755685A4
(en)
|
2004-05-28 |
2008-11-12 |
Mayo Foundation |
METHODS FOR TRANSPLANTATION OF AUTOLOGOUS STEM CELLS
|
|
JP5525689B2
(ja)
|
2004-11-02 |
2014-06-18 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
過剰増殖性障害を処置するための組成物および方法
|
|
JP5138380B2
(ja)
|
2004-11-24 |
2013-02-06 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
動物における免疫応答を増大させる方法
|
|
AU2006224313B2
(en)
|
2005-03-17 |
2011-08-11 |
Ucl Biomedica Plc |
Method for actvating Natural Killer cells by tumor cell preparation in vitro
|
|
ES2368152T3
(es)
|
2005-07-01 |
2011-11-14 |
Txcell S.A. |
Obtención de células tr1 específicas de antígenos de los alimentos o de autoantígenos a partir de una población de leucocitos o pbmc.
|
|
US9121008B2
(en)
|
2005-08-31 |
2015-09-01 |
University Of Utah Research Foundation |
Development of natural killer cells and functional natural killer cell lines
|
|
SI1941027T1
(sl)
|
2005-09-28 |
2014-11-28 |
Ipd-Theapeutics B.V. |
Postopki in sredstva za proliferacijo zarodnih celic in kasnejšo generacijo in ekspanzijo progenitorskih celic, kot tudi izdelava efektor celic kot kliničnih zdravil
|
|
WO2007103901A2
(en)
|
2006-03-06 |
2007-09-13 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer
|
|
WO2008118369A2
(en)
|
2007-03-22 |
2008-10-02 |
Dendreon Corporation |
Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity
|
|
ES2638435T3
(es)
|
2007-03-27 |
2017-10-20 |
Ipd-Therapeutics B.V. |
Métodos y medios para proliferación de células madre y posterior generación y expansión de células progenitoras, así como también producción de células efectoras como terapéuticos clínicos
|
|
KR100902340B1
(ko)
|
2007-08-02 |
2009-06-12 |
한국생명공학연구원 |
Ｙｃ－１ 또는 ｉｌ－２１을 유효성분으로 포함하는자연살해세포 분화제 및 분화 방법
|
|
WO2009072003A2
(en)
|
2007-12-07 |
2009-06-11 |
Miltenyi Biotec Gmbh |
Sample processing system and methods
|
|
KR101133185B1
(ko)
|
2008-07-29 |
2012-04-06 |
서울대학교병원 |
자연살해세포의 증식방법
|
|
KR101077912B1
(ko)
*
|
2008-10-24 |
2011-10-31 |
주식회사 메디셀 |
제대혈로부터 효율적인 자연살해세포의 증식 및 분화 방법
|
|
KR101720961B1
(ko)
|
2009-02-27 |
2017-03-29 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
다능성 세포의 분화
|
|
US8877182B2
(en)
|
2009-03-26 |
2014-11-04 |
Cellprotect Nordic Pharmaceuticals Ab |
Expansion of NK cells
|
|
TW201127959A
(en)
|
2010-02-12 |
2011-08-16 |
Ivy Life Sciences Co Ltd |
Method of producing immune killer cell
|
|
WO2011103882A1
(en)
|
2010-02-24 |
2011-09-01 |
Ingo Schmidt-Wolf |
Method for the generation of a cik cell and nk cell population
|
|
MX342995B
(es)
|
2010-07-13 |
2016-10-21 |
Anthrogenesis Corp |
Métodos de generar células asesinas naturales.
|
|
KR101145391B1
(ko)
|
2010-08-16 |
2012-05-15 |
고려대학교 산학협력단 |
말초혈액으로부터 자연 살해세포의 증식 방법
|
|
TWI439275B
(zh)
|
2010-12-31 |
2014-06-01 |
Glory Biomedical Co Ltd |
一種人類自然殺手細胞之體外增殖方法
|
|
KR20120093002A
(ko)
|
2011-02-14 |
2012-08-22 |
(주)에이티젠 |
Ｎｋ 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트
|
|
ES2856825T3
(es)
|
2011-03-18 |
2021-09-28 |
Glycostem Therapeutics B V |
Generación de células NK y progenitores de células NK
|
|
JP5572863B2
(ja)
*
|
2011-06-24 |
2014-08-20 |
国立大学法人九州大学 |
Ｎｋ細胞の増幅方法
|
|
ES2652666T3
(es)
|
2011-12-22 |
2018-02-05 |
Mogam Biotechnology Institute |
Procedimiento de producción de linfocitos citolíticos naturales, linfocitos citolíticos naturales producidos de este modo y composición para el tratamiento de cánceres y enfermedades infecciosas que contienen los mismos
|
|
DK2812011T3
(da)
|
2012-02-08 |
2020-02-24 |
Glycostem Therapeutics B V |
Differentiering ex vivo af nk-celler fra cd34+ hæmatopoietiske celler
|
|
EP2841563B1
(en)
|
2012-04-24 |
2019-06-12 |
Dan S. Kaufman |
Method for developing natural killer cells from stem cells
|
|
CN104321425B
(zh)
*
|
2012-05-07 |
2018-08-10 |
株式会社Nkmax |
用于诱导和扩增源自外周血单个核细胞的自然杀伤细胞的方法
|
|
EP3578201B1
(en)
|
2012-06-28 |
2023-04-19 |
University Of Central Florida Research Foundation Incorporated |
Methods and compositions for natural killer cells
|
|
US9175266B2
(en)
*
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
|
JP5856025B2
(ja)
|
2012-08-02 |
2016-02-09 |
阿部 博幸 |
単球またはｎｋ細胞を入手する方法
|
|
CN102988415B
(zh)
|
2012-08-15 |
2014-11-19 |
中航（宁夏）生物有限责任公司 |
人异基因有核细胞工业化制备自然杀伤性细胞(nk)及注射液
|
|
ES2719255T3
(es)
|
2012-11-21 |
2019-07-09 |
Inst Nat Sante Rech Med |
Métodos para determinar el riesgo de enfermedad aguda del injerto contra el hospedador
|
|
EP2947144B1
(en)
|
2013-01-15 |
2020-09-09 |
Hiroyuki Abe |
Method for manufacturing immunocyte-containing composition, and cancer-treating composition
|
|
AU2014215458A1
(en)
*
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
|
US9580486B2
(en)
|
2013-03-14 |
2017-02-28 |
Amgen Inc. |
Interleukin-2 muteins for the expansion of T-regulatory cells
|
|
DK2986312T3
(da)
|
2013-04-19 |
2022-02-14 |
Cytune Pharma |
Cytokinafledt behandling med reduceret vaskulært lækagesyndrom
|
|
EP3057986B1
(en)
|
2013-10-17 |
2017-12-27 |
National University of Singapore |
Chimeric receptor that triggers antibody-dependent cell cytotoxicity against multiple tumors
|
|
CN106103701B
(zh)
|
2014-01-03 |
2020-04-24 |
中央研究院 |
改造的自然杀手细胞及其组成与用途
|
|
WO2015125113A1
(en)
|
2014-02-21 |
2015-08-27 |
Dr. Reddy's Laboratories Limited |
Method of culturing high cell density pbmc's
|
|
JP6775426B2
(ja)
*
|
2014-03-07 |
2020-10-28 |
エメルセル エスエーエス |
臍帯血由来のプールｎｋ細胞並びにがん及び慢性感染症の治療のためのこれらの用途
|
|
WO2015154012A1
(en)
|
2014-04-03 |
2015-10-08 |
Memorial Sloan-Kettering Cancer Center |
Clonogenic natural killer (nk) cell populations and methods of producing and using such populations
|
|
AU2015259877B2
(en)
|
2014-05-15 |
2021-02-25 |
National University Of Singapore |
Modified natural killer cells and uses thereof
|
|
AU2015273501B2
(en)
|
2014-06-11 |
2021-01-21 |
Polybiocept Gmbh |
Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy
|
|
JP2016008198A
(ja)
|
2014-06-24 |
2016-01-18 |
国立大学法人名古屋大学 |
間質性膀胱炎の治療
|
|
WO2016007506A1
(en)
|
2014-07-07 |
2016-01-14 |
Targazyme, Inc. |
Manufacture and cryopreservation of fucosylated cells for therapeutic use
|
|
JP2016077185A
(ja)
|
2014-10-14 |
2016-05-16 |
学校法人 聖マリアンナ医科大学 |
γδＴ細胞の製造方法および医薬
|
|
SI3221349T1
(sl)
|
2014-11-19 |
2021-02-26 |
Axon Neuroscience Se |
Humanizirano tau protitelo pri alzheimerjevi bolezni
|
|
EP3034092A1
(en)
|
2014-12-17 |
2016-06-22 |
Université de Lausanne |
Adoptive immunotherapy for treating cancer
|
|
US20180021378A1
(en)
|
2014-12-31 |
2018-01-25 |
Anthrogenesis Corporation |
Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
|
|
WO2016122014A1
(ko)
|
2015-01-27 |
2016-08-04 |
한국생명공학연구원 |
자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도
|
|
CN104705291A
(zh)
|
2015-04-03 |
2015-06-17 |
广州赛莱拉干细胞科技股份有限公司 |
一种脐血单个核细胞冻存液、应用、制备方法
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
WO2016209021A1
(ko)
|
2015-06-24 |
2016-12-29 |
주식회사 차바이오텍 |
자연살해세포의 증식 방법 및 자연살해세포 증식용 조성물
|
|
KR101851270B1
(ko)
|
2015-07-10 |
2018-04-25 |
고려대학교 산학협력단 |
자연 살해세포의 대량증식 방법 및 배양용 조성물
|
|
EP3138905A1
(en)
|
2015-09-04 |
2017-03-08 |
Miltenyi Biotec GmbH |
Method for natural killer cell expansion
|
|
WO2017106656A1
(en)
|
2015-12-17 |
2017-06-22 |
Novartis Ag |
Antibody molecules to pd-1 and uses thereof
|
|
CN105524880A
(zh)
|
2016-01-27 |
2016-04-27 |
上海润泉生物技术有限公司 |
一种免疫细胞库的构建方法
|
|
CN107267454B
(zh)
|
2016-04-07 |
2025-05-23 |
内蒙古原生元生物科技有限公司 |
一种脐血nk细胞的体外扩增方法及其试剂盒与应用
|
|
KR101968184B1
(ko)
*
|
2016-04-29 |
2019-04-15 |
고려대학교 산학협력단 |
저산소 조건을 이용한 면역세포의 증식 배양 방법
|
|
CN109843304A
(zh)
|
2016-05-07 |
2019-06-04 |
细胞结构公司 |
使用自然杀伤细胞治疗急性髓性白血病和多发性骨髓瘤的方法
|
|
CN109844099B
(zh)
|
2016-07-25 |
2024-01-02 |
美国政府(由卫生和人类服务部的部长所代表) |
产生经修饰的自然杀伤细胞的方法及使用方法
|
|
ES3014658T3
(en)
|
2016-10-05 |
2025-04-23 |
Univ Central Florida Res Found Inc |
Methods and compositions related to nk cell and anti-pdl1 cancer therapies
|
|
US10300089B2
(en)
|
2016-11-08 |
2019-05-28 |
University Of Central Florida Research Foundation, Inc. |
Methods for high scale therapeutic production of memory NK cells
|
|
US11504396B2
(en)
|
2016-12-21 |
2022-11-22 |
Nkmax Co., Ltd. |
Pharmaceutical composition and methods comprising immune cells and ponatinib
|
|
WO2018161026A1
(en)
*
|
2017-03-03 |
2018-09-07 |
Obsidian Therapeutics, Inc. |
Il15 compositions and methods for immunotherapy
|
|
KR101948534B1
(ko)
|
2017-04-20 |
2019-02-15 |
주식회사 이뮤니스바이오 |
세포밀도 조절을 이용한 자연살해세포의 대량증식방법
|
|
EP3633029A4
(en)
|
2017-05-26 |
2021-06-09 |
Green Cross Lab Cell Corporation |
METHOD OF DEVELOPING A NATURAL KILLER CELL USING A T-CELL
|
|
WO2019014684A1
(en)
|
2017-07-14 |
2019-01-17 |
Ohio State Innovation Foundation |
EXPANSION OF IMMUNE CELLS WITH INTERLEUKIN-INDUCIBLE T CELL KINASE-INHIBITING COMPOUNDS
|
|
WO2019028419A1
(en)
|
2017-08-03 |
2019-02-07 |
Synthorx, Inc. |
CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES
|
|
US20210128567A1
(en)
|
2017-08-29 |
2021-05-06 |
Flaask, Llc |
Compositions and Methods for Cognitive, Immune and Digestive Support in Patients with Autism Spectrum Disorder
|
|
CN107970258B
(zh)
|
2017-11-20 |
2020-11-10 |
英普乐孚生物技术(上海)有限公司 |
一种嵌合抗原受体t细胞制剂
|
|
WO2019152663A1
(en)
|
2018-02-01 |
2019-08-08 |
Nkmax Co., Ltd. |
Method of producing natural killer cells and composition for treating cancer
|
|
KR102732845B1
(ko)
|
2018-02-01 |
2024-11-25 |
주식회사 엔케이맥스 |
자연살해세포의 생산방법
|
|
KR102765799B1
(ko)
|
2018-02-01 |
2025-02-13 |
주식회사 엔케이맥스 |
Cd56+ 자연살해세포를 포함하는 항암용 조성물
|
|
EP3746095A4
(en)
|
2018-02-01 |
2021-04-21 |
Nkmax Co., Ltd. |
Method of producing natural killer cells and composition for treating cancer
|
|
PT3755347T
(pt)
|
2018-02-21 |
2025-07-25 |
Univ Texas |
Células de apresentação de antigénio universais e utilizações destas
|
|
WO2019168222A1
(ko)
|
2018-02-28 |
2019-09-06 |
주식회사 제넨셀 |
말초혈액단핵구 유래 항암 활성화 림프구 배양용 배지 조성물 및 이를 이용한 항암 활성화 림프구 배양방법
|
|
US20230181635A1
(en)
|
2018-03-13 |
2023-06-15 |
Fundación Para La Investigación Biomédica Del Hospital Universitario La Paz |
Anti-cxcr4 antibody combined with activated and expanded natural killer cells for cancer immunotherapy
|
|
EP3539552A1
(en)
|
2018-03-16 |
2019-09-18 |
Deutsches Rheuma-Forschungszentrum Berlin |
Activation and expansion of nkg2c+ nk cells
|
|
WO2019182392A1
(ko)
|
2018-03-23 |
2019-09-26 |
주식회사 녹십자랩셀 |
자연살해세포의 제조방법
|
|
MX2020011697A
(es)
|
2018-05-03 |
2020-12-10 |
Univ Texas |
Células exterminadoras naturales diseñadas para expresar receptores de antígeno quimérico con bloqueo de punto de control inmunitario.
|
|
JP2021525066A
(ja)
|
2018-05-30 |
2021-09-24 |
グリコステム セラピューティクス ベスローテン フェンノートシャップ |
Ｃａｒ ｎｋ細胞
|
|
WO2020006139A1
(en)
|
2018-06-27 |
2020-01-02 |
The George Washington University |
Targeting stat sumoylation to enhance immune responses
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
CN109294985B
(zh)
|
2018-10-25 |
2022-02-18 |
江苏普瑞康生物医药科技有限公司 |
一种用于nk细胞体外扩增的培养基体系及nk细胞体外扩增的方法
|
|
KR20210111746A
(ko)
|
2018-11-08 |
2021-09-13 |
감마델타 테라퓨틱스 리미티드 |
세포를 단리 및 증식하는 방법
|
|
WO2020101361A1
(ko)
|
2018-11-14 |
2020-05-22 |
주식회사 녹십자랩셀 |
형질전환된 t세포를 이용한 제대혈 유래 자연살해세포의 배양방법
|
|
CN111205361B
(zh)
|
2018-11-22 |
2022-05-06 |
海珂分子（北京）科技有限责任公司 |
白介素21蛋白(il21)突变体及其应用
|
|
EP3656851A1
(en)
|
2018-11-23 |
2020-05-27 |
Technische Universität Dresden |
Artificial hla-positive feeder cell lines for nk cells and uses thereof
|
|
US12590148B2
(en)
|
2018-11-26 |
2026-03-31 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
MX2021006393A
(es)
|
2018-11-29 |
2021-10-13 |
Univ Texas |
Metodos para expansion ex vivo de celulas exterminadoras naturales y uso de las mismas.
|
|
KR20210113265A
(ko)
|
2019-01-07 |
2021-09-15 |
인히브릭스, 인크. |
변형된 il-2 폴리펩타이드를 포함하는 폴리펩타이드 및 이의 용도
|
|
EP3927730A4
(en)
|
2019-02-20 |
2022-12-21 |
Rutgers, The State University of New Jersey |
EXPANSION OF NATURAL KILLER CELLS AND CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS
|
|
CU24712B1
(es)
|
2019-03-15 |
2024-07-10 |
Centre Hospitalier Univ Vaudois |
Método para la expansión y diferenciación de linfocitos t y células nk en terapias de transferencia adoptiva
|
|
WO2020205359A1
(en)
|
2019-03-29 |
2020-10-08 |
Board Of Regents, The University Of Texas System |
Methods for production of car-nk cells and use thereof
|
|
KR20220026575A
(ko)
|
2019-06-25 |
2022-03-04 |
시티 오브 호프 |
Pdl1 양성 nk 세포 암 치료
|
|
JP2023505102A
(ja)
|
2019-11-29 |
2023-02-08 |
エヌケーマックス カンパニー リミテッド |
ナチュラルキラー細胞を製造する方法およびその組成物
|
|
US20250195574A1
(en)
|
2022-06-02 |
2025-06-19 |
Nkmax Co., Ltd. |
Method for reduction of immune checkpoint therapy related adverse events
|
|
KR20250044875A
(ko)
|
2022-07-12 |
2025-04-01 |
주식회사 엔케이맥스 |
확장된 자연살해세포를 이용한 파킨슨병 치료방법
|
|
US20260048083A1
(en)
|
2022-08-10 |
2026-02-19 |
Nkmax Co., Ltd. |
Method of treating alzheimer's disease with expanded natural killer cells
|
|
WO2024036226A1
(en)
|
2022-08-10 |
2024-02-15 |
Nkmax Co., Ltd. |
Method of treating autism with expanded natural killer cells
|